Clinical Trials
21 trialsNCT02755844 2026-05-27
ENDOLA
Hospices Civils de Lyon
Phase 1/2 Completed
NCT07146919 2026-04-23
ANGELICA
Centre Leon Berard
Phase 1/2 Withdrawn
NCT05559879 2026-04-15
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
Phase 1/2 Recruiting
NCT04486352 2026-04-01
EndoMAP
Alliance Foundation Trials, LLC.
Phase 1/2 Recruiting
NCT05269381 2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2 Recruiting
NCT04683653 2025-12-29
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
University of Chicago
Phase 1/2 Recruiting
NCT05057013 2025-08-11
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Cancer Research UK
Phase 1/2 Active not recruiting
NCT05714553 2025-07-18
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Phase 1/2 Terminated
NCT02632448 2025-05-02
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Esperas Pharma Inc.
Phase 1/2 Completed
NCT04514692 2025-04-23
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
Stanford University
Phase 1/2 Terminated
NCT06385548 2025-04-01
LiDer
Vall d'Hebron Institute of Oncology
Phase 1/2 Withdrawn
NCT05869123 2024-11-21
Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
Peking Union Medical College Hospital
Phase 1/2 Active not recruiting
NCT04823065 2024-05-13
4FMFES-PET Imaging of Endometrial and Ovarian Cancers
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Phase 1/2 Completed
NCT02730923 2024-02-13
VICTORIA
Centre Leon Berard
Phase 1/2 Unknown
NCT04631731 2023-06-01
ICEMELT
Western Sydney Local Health District
Phase 1/2 Unknown
NCT04014530 2023-02-01
ATAPEMBRO
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1/2 Recruiting
NCT03572478 2021-03-09
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
University of Chicago
Phase 1/2 Terminated
NCT01097239 2020-11-20
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer
Imperial College London
Phase 1/2 Withdrawn
NCT04157491 2019-11-08
Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer
Sun Yat-sen University
Phase 1/2 Unknown
NCT02907073 2019-05-17
Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
Mayo Clinic
Phase 1/2 Terminated
NCT00032162 2012-05-31
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
AGO Study Group
Phase 1/2 Completed